Showing posts with label literature. Show all posts
Showing posts with label literature. Show all posts

Thursday, March 3, 2011

Why easy is not always good

My mother-in-law is a typesetter. She will not read a book unless it is not only appealing in its content, but also pleasing to the eye. When I was in medical school, she did quite a bit of work for medical textbook publishers. Comparing books typeset by her to what I was grinding through on a daily (and nightly basis) incensed her: unwieldy tables appearing three pages away from the corresponding text, small letters crammed to capacity onto oversized pages, few illustrations -- all baffling, annoying (and easily fixable) transgressions against readability. Yet, like all budding docs of all generations, I plowed through these morasses of knowledge without giving its readability much thought -- this was just what you did to get to your goal.

Yesterday I was listening to a program where the author Amy Chua was interviewed about her (ahem) embattled autobiography Battle Hymn of the Tiger Mother. Ms. Chua, though evenly humored throughout the interview, was on the defensive nearly the entire time, explaining how the intent of her opus has been grossly misunderstood by the public, thanks to attacks by critics on her parenting style. And granted, looking at the book as a parenting manual through the prism of our Western parenting norms is a bit disturbing. Yet putting its events in a culturally appropriate context, as well as looking at the content as a narrative rather than a guide, leads to completely different conclusions.

Why am I bringing up Amy Chua's interview after talking about my conquest of the unreadable? Well, it seems that ease is what we have come to expect from everything. What I mean by this is that not only do we expect easily readable texts, but we also expect people to present themselves in such a way as to make it easy for us to like them. Why else change your appearance through life-threatening eating disorders and grueling surgeries, get coached on how to make friends and influence people, and comment on how unlikable some of our female politicians are? Is this not a triumph of form over substance?

Amy Chua clearly bucks this trend in her book and is paying the price. But what worries me is that we are all paying a price. By creating another false dichotomy of "she is nice" or "he is nasty", we have eschewed a more realistic view of our human foibles. We are all nice sometimes and nasty at others. Yet this dichotomy has proven supremely fruitful to our political discourse, where for 30 years this new reality has been taking root. And it has born fruit, so that now people who do not hold similar opinions to ours are summarily dismissed as "nasty" or idiotic, and we are satisfied to surround ourselves with "nice" like-minded sycophants. How primitive it renders our political and social interactions!

Ms. Chua's immigrant parents' philosophy resonated with my upbringing. Coming from lands of uncertainty and deprivation, as immigrants, our parents subscribed to Maslow's pyramid and taught us that economic security trumped everything else. This is why only certain career choices were acceptable, while others were relegated to the back burner of a hobby. These choices were not about ease, but about doing what we were taught was the right thing. As John Adams said:
I must study Politicks and War that my sons may have liberty to study Mathematicks and Philosophy. My sons ought to study Mathematicks and Philosophy, Geography, natural History, Naval Architecture, navigation, Commerce, and Agriculture, in order to give their Children a right to study Painting, Poetry, Musick, Architecture, Statuary, Tapestry, and Porcelaine.
We all set priorities, and some of them may not be easy. I myself still read books even if they are not all that well presented; my priorities are content and writing style, though, to be sure, I do not frown upon the beauty of the visual form. I even enjoy characters who in, their multidimensionality, are a challenge to like. And I have learned in the rest of my life to enjoy people who do not necessarily hold easy or quick appeal for me, yet in the long run prove to add unimaginable richness to my life. Nietzsche coined the famous quote "What does not break you will make you stronger." In all aspects of our lives, while, based on Nietzsche's statement, adversity is a sufficient but not necessary road to strength, pushing ourselves a little bit out of our stuporous ease may prove to be one timely remedy.

Friday, January 7, 2011

Reviewing medical literature, part 2a: Study design

It is true that the study question should inform the study design. I am sure you are aware of the broadest categorization of study design -- observational vs. interventional. When I read a study, after identifying the research question I go through a simple 4-step exercise:
1. I look for what the authors say their study design is. This should be pretty easily accessible early in the Methods section of the paper, though that is not always the case. If it is available,
2. I mentally judge whether or not it is feasible to derive an answer to the posed question using the current study design. For example, I spend a lot of time thinking about issues of therapeutic effectiveness and cost-effectiveness, and a randomized controlled trial exploring efficacy of a therapy cannot adequately answer the effectiveness questions.
If the design of the study appears appropriate,
3. I structure my reading of the paper in such a way as to verify that the stated design is, in fact, the actual design. If it is, then I move on to evaluate other components of the paper. If it is not what the authors say,
4. I assign my own understanding to the actual design at hand an go through the same mental list as above with the current understanding in mind.

Here is a scheme that I often use to categorize study designs:
As already mentioned, the first broad division is between observational studies and interventional trials. An anecdote from my course this past semester illustrates that this is not always a straight-forward distinction to make. In my class we were looking at this sub-study of the Women's Health Initiative (WHI), that pesky undertaking that sank the post-menopausal hormone replacement enterprise. The data for the study were derived from the 3 randomized controlled trials (RCT) of HRT, diet and calcium and vitamin D, as well as from the observational component of the WHI. So, is it observational or interventional? The answer to this is confusing to the point of pulling the wool over even experienced clinicians' eyes, as became obvious in my class. To answer the question, we need to go back to definitions of "interventional" and "observational". To qualify as an interventional, a study needs to have the intervention be a deliberate part of the study design. A common example of this type of a study is the randomized controlled trial, the sine qua non of drug evaluation and approval process. Here the drug is administered as a part of the study, not as a background of regular treatment. In contradistinction, an observational study is just that: an opportunistic observation of what is happening to a group of people under ordinary circumstances. Here no specific treatment is predetermined by the study design. Given that the above study looked at multivitamin supplementation as the main exposure, despite its utilization of the data from RCTs, the study was observational. So, the moral of this tale is to be vigilant and examine the design carefully and thoroughly.

We often hear that observational designs are well suited to hypothesis generation only. Well, this is both true and false. Some studies actually can test hypotheses, while others are relegated to generation only. For example, cross-sectional and ecological studies are well suited to generating hypotheses to be tested by another design. To take a recent controversy as an example, the debunked link between vaccinations and autism initially gained steam from the observation that as the vaccination rates were rising, so was the incidence of autism. The type of a study that shows two events changing at the group/population level either in the same or in the opposite direction is called "ecologic". Similar types of studies gave rise to the vitamin D and cancer association hypothesis, showing geographic variation in cancer rates based on the availability of sun exposure. But, as demonstrated well by the vaccine-autism debacle, running with the links from ecological studies is dangerous, as they are prone to a so-called "ecological fallacy". It occurs when, despite the finding in groups of a linked change of the two factors under investigation, there is absolutely no connection between them at the individual level. So, don't let anyone tell you that they tested an hypothesis in an ecological study!

Similarly in cross-sectional studies an hypothesis cannot be tested, and, therefore, causation cannot be "proven". This is due to the fundamental property of "a snapshot in time" that defines a cross sectional study. Since all events (with few minor exceptions) happen at the same time, it is not possible to assign causation to the exposure-outcome couplet. These studies can merely help us think of further questions to test.

So, to connect the design back to the question, if a study purports to "explore a link between exposure X and outcome Y", either an ecologic or a cross-sectional design is OK. On the other hand, if you see one of these designs used to "test the hypothesis that exposure X causes outcome Y", run the other way screaming.

We will stop here for now, and in the next post will continue our discussion of study designs. Not sure yet if we can finish it in one more post, or if it will require multiple postings. Start praying to the goddess of conciseness now!

    

Reviewing medical literature, part 1: The study question

Let's start at the beginning. Why do we do research and write papers? No, not just to get famous, tenured or funded. The fundamental task of science is to answer questions. The big questions of all time get broken down into infinitesimally small chunks that can be answered with experimental or observational scientific methods. These answers integrated together provide the model for life as we understand it.

Clearly, the question is the most important part of the equation, and this is why in my semester-long graduate epidemiology course on the evaluative sciences we spend fully the first four to five weeks talking about how to develop a valid and answerable question. The cornerstone of this validity is its importance. Hence, the first question that we pose is: Is the study question important?

This is a bit of a loaded question, though. Important to whom? How is "important" defined? This is somewhat subjective, yet needs to be scrutinized nevertheless. In the context of an individual patient, the question may become: Is the study question important to me? So, importance is dependent on perspective. Nevertheless, there are questions upon whose importance we can all agree. For example, the importance of the question of whether our current fast-food life style promotes obesity and diabetes is hard to dispute.

Regardless of how we feel about the importance of the question, we must first identify the said research question. At least some of the time you will be able to find it in the primary paper, buried in the last paragraph of the Introduction section. Most of the questions we ask relate to etiologic relationships ("etiology" is medicalese for "causation"). Now, you have heard many times that an observational study cannot answer a causal question. Yet, why do we bother with the time, energy and money needed to run observational studies? Without getting too much into the weeds, philosophers of science tell us that no single study design can give us unequivocal evidence of causality. We can merely come close to it. What does this mean in practical terms? It means that, although most observational studies are still interested in causality rather than a mere association, we have to be more circumspect in how we interpret the results from such studies than from interventional ones. But I am jumping ahead.

Once we have identified and established the importance of the question, we need to evaluate its quality. A question of high quality is 1). clear, 2). specific, and 3). answerable. The question that I posed above regarding fast food and obesity possesses none of these characteristics. It is too broad and open to interpretation. If I were really posing a question in this vein, I would choose a single well defined exposure (consuming 3 cans of soda per day) influencing a single outcome (10% body weight gain) over a specific period of time (over 30 weeks). While this is a much narrower question that the one I proposed above, it is only by answering bundles of such narrow questions and putting the information together that we can arrive at the big picture.

A general principle that I like to teach to my student is the PICO or PECOT model (I did not come up with it, but am its avid user). In PICO, P=population, I=intervention or exposure, C=comparator, and O=outcome. The PECOT model is an adaptation of the PICO for observations over time, resulting in P=population, E=exposure, C=comparator, O=outcome, T=time. These models can help not only pose the question, but to unravel the often mysterious and far from transparent intent of the investigators.

Once you have identified the question and dealt with its importance, you are ready to move on to the next step: evaluating the study design as it relates to the question at hand. We will discuss this in the next post.

Series launch: Critical review of medical literature

Today I am launching a series of posts on how to read medical literature critically. The series should provide a solid foundation for this task and dove-tail nicely with some of the more dense methods themes that occur on this blog. Who should read the series? Everyone. Although the current model of dissemination of medical information relies on a layer of translators (journalists and clinicians), it is my belief that every educated patient must at the very least understand how these interpreters of medical knowledge (should) examine it to arrive at the information imparted to the public. At the same time, both journalists and clinicians may benefit from this refresher. Finally, my own pet project is to get to a better place with peer reviews -- you know how variable the quality of those can be from my previous posts. So, I particularly encourage new peer reviewers for clinical journals to read this series.  

First, a conflict of interest statement. What comes first -- the chicken or the egg? What comes first -- expertise in something or a company hiring you to develop a product? Well, in my case I would like to think that it was the expertise that came first and that Pfizer asked me to develop this content based on what I know, not on the fact that they funded the effort. At any rate, this is my disclaimer: I developed this presentation about three years ago with (modest) funding from Pfizer, and they had it on a web site intended for physician access. Does this mere fact invalidate what I have to say? I don't think so, but you be the judge.

Roughly, the series will examine how to evaluate the following components of any study:
1. Study question
2. Study design
3. Study analyses
4. Study results
5. Study reporting
6. Study conclusions
I am not trying to give you a comprehensive course on how all of this is done, but merely make the reader aware of what entails a critical review of a paper.

Look for the first installment of the series shortly.